UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000024676
Receipt No. R000028387
Scientific Title A randomized, double-blind, placebo-controlled phase III trial evaluating olanzapine 5mg combined with standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy: J-SUPPORT 1604
Date of disclosure of the study information 2016/11/01
Last modified on 2019/05/04 13:08:34

No. Disposal Last modified on Item of update
1 Insert 2016/11/01 21:52:05
2 Update 2017/03/19 15:08:04 Recruitment status
Anticipated trial start date
3 Update 2017/05/31 09:38:30 Email1
Email2
4 Update 2018/11/05 14:04:26 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
5 Update 2019/04/09 17:13:23 Date of IRB
Date analysis concluded
6 Update 2019/04/09 17:18:34 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
7 Update 2019/05/04 13:08:34 Recruitment status


Contact us.